SpringWorks Therapeutics (SWTX) Competitor Comparison
We are evaluating the key criteria listed to compare SpringWorks Therapeutics (SWTX) against its competitors in the Biotechnology industry.
Market Capitalization
47 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
305 / 337Free Cashflow
303 / 352Quick Ratio
105 / 357Earnings per Share
292 / 359Dividend yield
0 / 6Total Cash
72 / 358Performance 3 years
151 / 368Performance 5 years
71 / 368Performance 10 years
81 / 368Linearity 3 years
118 / 368Linearity 5 years
69 / 368Linearity 10 years
46 / 368Total Rank
267 / 368Dividend Rank
276 / 368Valuation Rank
59 / 368Piotroski Rank
48 / 368Muliplier Rank
210 / 368EBITDA - SWTX ranking 305 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.